Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-24-000002

Options or other derivatives

  • Chief Medical Officer acquired 33,779 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sumner Michael John Chief Medical Officer 2024-02-28 Grant or award · Common Stock Option +18,750 18,750 D: show line 1 in the form
Sumner Michael John Chief Medical Officer 2024-02-28 Grant or award · Restricted Stock Unit +15,029 15,029 D: show line 2 in the form
Loading xslF345X05/wk-form4_1709157796.xml…